Figure 5 | Scientific Reports

Figure 5

From: Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease

Figure 5

Ability of LPC(14:0) to discriminate DILD from other lung diseases and healthy volunteers. (A) Plasma LPC(14:0) concentrations in acute phase DILD patients, other lung diseases, and healthy volunteers. ***p < 0.001, *p < 0.05 vs. acute phase DILD. LuCa; lung cancer, BaPn; bacterial pneumonia, NoMy; nontuberculous mycobacteriosis, IIP; idiopathic interstitial pneumonia, CTD; lung disease associated with connective tissue disease, COPD; chronic obstructive pulmonary disease, BrAs; bronchial asthma, Healthy; healthy volunteer. (B) ROC curve of LPC (14:0) concentrations between acute phase DILD patients and other groups.

Back to article page